A novel stratification framework based on vascular-fibrotic complications identifies distinct risk endotypes in systemic sclerosis: A retrospective cohort study
Journal of the American Academy of Dermatology · 2026
DOI: 10.1016/j.jaad.2026.05.034 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of the American Academy of Dermatology, 2026. Verfasst von Huidan Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Skin, Vascular Diseases. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Systemic sclerosis (SSc) is highly heterogeneous, and the traditional skin-based classification inadequately guides organ-specific management or predicts prognosis. OBJECTIVE: To develop and validate a novel stratification framework based on dominant vascular and fibrotic complications to identify distinct risk endotypes. METHODS: This retrospective cohort study included 281 SSc patients categorized at baseline into 4 subgroups: Vascular-dominant, Fibrotic-dominant, Mixed (both), and Limited (neither). Clinical, serological, and immunophenotypic data were compared. Longitudinal progression was analyzed using Kaplan-Meier and Cox regression. RESULTS: Four distinct endotypes were identified. The Mixed subgroup (n = 47) was characterized by cytopenias, Th17/Treg imbalance, elevated IL-6, and specific autoantibodies. It demonstrated the shortest median progression-free survival (36 months) and the highest independent risk of disease progression (adjusted hazard ratio = 3.194, 95% confidence interval: 1.219-8.369). Biomarker combinations showed moderate predictive value for subgroup identification. LIMITATIONS: This single-center study has a moderate sample size, an incomplete biomarker panel, and a relatively short follow-up duration, which may limit generalizability and comprehensive progression assessment. CONCLUSION: We establish a novel complication-based framework that identifies a high-risk. Mixed vascular-fibrotic endotype, providing a pragmatic tool for early risk stratification and personalized management in SSc.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
- Department of Rheumatology, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China; Shanxi Provincial Technology Innovation Center for Immunogenetics and Rare Diseases, Taiyuan, Shanxi, China.
- Department of Rheumatology, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China; Shanxi Provincial Technology Innovation Center for Immunogenetics and Rare Diseases, Taiyuan, Shanxi, China. Electroni…
Zitieren
APA
Yang, H., Cheng, H., Li, J., Zhang, M., Zhao, Q., Wang, K., Yan, C., & Wen, H. (2026). A novel stratification framework based on vascular-fibrotic complications identifies distinct risk endotypes in systemic sclerosis: A retrospective cohort study. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2026.05.034
Vancouver
Yang H, Cheng H, Li J, Zhang M, Zhao Q, Wang K, et al. A novel stratification framework based on vascular-fibrotic complications identifies distinct risk endotypes in systemic sclerosis: A retrospective cohort study. Journal of the American Academy of Dermatology. 2026. doi:10.1016/j.jaad.2026.05.034
BibTeX
@article{Yang2026,
author = {Yang, Huidan and Cheng, Hao and Li, Juanjuan and Zhang, Mingyang and Zhao, Qiong and Wang, Kai and Yan, Chenglan and Wen, Hongyan},
title = {A novel stratification framework based on vascular-fibrotic complications identifies distinct risk endotypes in systemic sclerosis: A retrospective cohort study},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
doi = {10.1016/j.jaad.2026.05.034}
}
EUVIMED